Patient preferences for EGFR mutation-targeted therapies in non-small cell lung cancer, with a focus on Exon 20 insertions.

Jaein Seo, Eileen Curran, Jennifer A Whitty, Marcia K Horn, Tarek Mekhail, Huamao M Lin, Malavika Venkatraman, Nicolas Krucien, Anup Das, Sebastian Heidenreich, Jun Zhang